There's no denying that volatility in the stock markets over the past 18 months has presented challenges for investors across a range of risk tolerances and experience levels. Even so, there remains opportunity to invest in quality businesses that have compelling growth stories over the long run. 

If you have $2,500 to spare -- money that you don't need for bills or any other immediate expenses -- there is no shortage of quality stocks worthy of investing dollars. Here are two such stocks to consider right now. 

Vertex Pharmaceuticals (NASDAQ: VRTX) is known for its long-standing leadership in the cystic fibrosis therapeutics space, where it remains the only company with approved drugs that treat the underlying cause of the genetic disease. These drugs are known as CFTR modulators. In layperson's terms, these drugs act at the genetic level by working on the defective CFTR protein. Currently, Vertex's portfolio of four approved products are all CFTR modulators. The availability of these medicines has had a notable impact on what a cystic fibrosis diagnosis can mean for patients, in terms of both quality of life and longevity. 

Continue reading

Source Fool.com